Astria Therapeutics, Inc.
ATXSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted in 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.5M in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 141
- Q4 2025, +31 vs. previous quarter
- 13F value
- $738.5M
- Reported value at the end of Q4 2025
- Superinvestors holding
- 1
- At the end of Q4 2025
Superinvestors holding ATXS, Q4 2025
1 superinvestor reports holding Astria Therapeutics, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
0.2%
Astria Therapeutics, Inc.'s share of the portfolio
- Shares
- 873,400
- Value
- $11.4M
Latest insider trades
Open-market purchases and sales by Astria Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Morabito ChristopherChief Medical Officer | SSale | −10.0K | $13.59 | −$135.9K | −100.0%0 after | 10b5-1 |
| Feb 5, 2024 (view filing)5:02 PM ET | Feb 1 | 4 days | Edelman Joseph and 3 othersDirector | PPurchase | +2.48M | $12.09 | +$30.0M | +103.7%4.87M after | |
| Jan 30, 2024 (view filing) | Jan 26-29 | 4 days | Morabito ChristopherChief Medical Officer | SSale | −10.0K | $11.14 | −$111.4K | −100.0%0 after | 2 lots10b5-1 |
| Dec 22, 2023 (view filing)2:51 PM ET | Dec 21 | 1 day | Edelman Joseph and 3 othersDirector | PPurchase | +740.0K | $6.20 | +$4.59M | +44.8%2.39M after | |
| Oct 18, 2023 (view filing)4:11 PM ET | Oct 16 | 2 days | Edelman Joseph and 3 othersDirector | PPurchase | +1.07M | $6.51 | +$7.00M | +200.1%1.61M after | 2 lots |
| Oct 18, 2023 (view filing)4:11 PM ET | Oct 16 | 2 days | Edelman Joseph and 3 othersDirector | PPurchase | +2.42M | $7.86 | +$19.0M | –345.4K after | Derivative4 lots |
| Dec 21, 2022 (view filing)4:52 PM ET | Dec 19 | 2 days | Edelman Joseph and 3 othersDirector | PPurchase | +908.3K | $11.01 | +$10.0M | +698.4%1.04M after | |
| Nov 23, 2021 (view filing) | Nov 19 | 4 days | Komjathy AndrewChief Commercial Officer | PPurchase | +100 | $6.70 | +$670 | New position100 after |
Top 10 13F holders, Q4 2025
The largest institutional positions in Astria Therapeutics, Inc. at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 6,485,420 | $84.9M | 1.56% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,832,755 | $50.2M | 0.00% | +344,553+9.9% | Added |
| Glazer Capital, LLC | 3,776,154 | $49.4M | 1.30% | +3,776,154 | New |
| Magnetar Financial LLC | 3,431,007 | $44.9M | 0.44% | +3,431,007 | New |
| Vanguard Group Inc | 2,623,042 | $34.3M | 0.00% | −19,128−0.7% | Reduced |
| UBS Group AG | 2,399,171 | $31.4M | 0.01% | +1,819,020+313.5% | Added |
| Deutsche Bank AG | 1,762,802 | $23.1M | 0.01% | +1,729,463+5,187.5% | Added |
| Alliancebernstein L.P. | 1,732,464 | $22.7M | 0.01% | +1,674,494+2,888.6% | Added |
| Balyasny Asset Management LLC | 1,636,921 | $21.4M | 0.04% | +1,636,921 | New |
| Geode Capital Management, LLC | 1,073,766 | $14.1M | 0.00% | +115,522+12.1% | Added |